Adverse Effects of Androgen Deprivation Therapy: Defining the Problem and Promoting Health Among Men with Prostate Cancer
- 1 February 2010
- journal article
- Published by Harborside Press, LLC in Journal of the National Comprehensive Cancer Network
- Vol. 8 (2), 211-223
- https://doi.org/10.6004/jnccn.2010.0014
Abstract
Androgen deprivation therapy (ADT) plays a central role in the management of men with locally advanced, recurrent, and metastatic prostate cancer. Because most men diagnosed with prostate cancer will die of something other than their cancer, treatment-related adverse effects are highly relevant to their long-term health. Benefits of ADT in each clinical setting must be weighed against ADT-related adverse effects. ADT is detrimental to several metabolic end points and to bone health. ADT has been prospectively shown to cause decreased lean muscle mass, increased fat mass, weight gain, increased cholesterol and triglycerides, insulin resistance, and loss of bone mineral density. In population-based analyses it has been associated with an increased incidence of diabetes, clinical fractures, and cardiovascular disease. Data-driven recommendations for managing these adverse effects are needed. Currently the authors advocate the use of adapted practice guidelines developed to prevent diabetes, fractures, and coronary heart disease in the general population.Keywords
This publication has 87 references indexed in Scilit:
- Impact of Androgen Deprivation Therapy on Cardiovascular Disease and DiabetesJournal of Clinical Oncology, 2009
- International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of DiabetesDiabetes Care, 2009
- Risedronate Recovers Bone Loss in Patients With Prostate Cancer Undergoing Androgen-deprivation TherapyUrology, 2009
- Deaths: final data for 2006.2009
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2009
- Risk of Fracture after Androgen Deprivation for Prostate CancerNew England Journal of Medicine, 2005
- A family history of fracture and fracture risk: a meta-analysisBone, 2004
- Smoking and fracture risk: a meta-analysisOsteoporosis International, 2004
- Osteoporosis in Men*Journal of Clinical Endocrinology & Metabolism, 1999
- The structural basis of bone fragility in menBone, 1999